# Efficacy of Interleukin 8 (IL-8) in the detection of urinary tract infection

## TL;DR

This study explores whether IL-8 can be used as a biomarker to accurately detect urinary tract infections by measuring its levels in urine samples.

## Contribution

The study investigates IL-8 as a potential biomarker for UTI diagnosis, showing its efficacy in distinguishing true infections from contamination.

## Key findings

- IL-8 levels showed a significant difference between non-infected and UTI samples.
- Lactoferrin was the only other biomarker with comparable results to IL-8.
- IL-8 testing combined with bacterial detection could improve UTI diagnosis accuracy.

## Abstract

Urinary tract infection (UTI) is the most common bacterial infection independent of age. Currently, the gold standard for diagnosis of UTI is based on the presence of bacteria together with white blood cells in the urine to distinguish significant infection vs contamination. Unfortunately, white blood cell count in the urine is non-specific. An ideal biomarker should be elevated in all UTIs, irrespective of the causative organism, and remain low in the absence of infection or systemic inflammation. The purpose of this proof-of- concept study was to examine whether IL-8 could act as an efficacious biomarker for UTI infection in combination with confirmed bacterial infection.

In this study, IL-8 levels were measured in anonymised urine samples sent to the pathology laboratory for microbiology testing using commercially available ELISA kits. The urine samples tested had laboratory confirmed infection with Escherichia coli, Proteus, or Klebsiella bacteria.

The results demonstrated that although the IL-8 levels were variable for the 3 different causative agents of UTI tested, there was a significant difference between no growth samples and combined UTI samples. Of other biomarkers tested only lactoferrin gave comparable results to IL-8.

The IL-8 data presented is consistent with other published work and suggests that testing for IL-8 with measurement of uropathogenic bacteria could be a sensitive screening test for an accurate diagnosis of active UTI infection, excluding contamination and systemic inflammation. Larger studies with integrated clinical data are necessary to explore this further.